跳至內容

使用者:Zorro tnbz/sandbox

維基百科,自由的百科全書

還想和你再手牽手走過開心十年 現在就在燭光裏臉靠臉 臉靠臉 oh 親愛的請別壓抑時空變換一樣愛你 祝你開心十年 oh 親愛的請別哭泣點燃回憶吹熄傷心 祝你開心十年 多麼幸運彼此遇見 柴米油鹽才最可貴 每年就這天最特別祝你開心十年 歲月是讓人老一點可是開心十年 還想和你再手牽手重溫開心十年 現在就讓我抱你許個願 許個願 oh 親愛的請別壓抑一樣愛你十年 oh 親愛的請別哭泣祝你開心十年






File:Islet.png
A porcine islet of Langerhans. The left image is a brightfield image created using hematoxylin stain; nuclei are dark circles and the acinar pancreatic tissue is darker than the islet tissue. The right image is the same section stained by immunofluorescence against insulin, indicating beta cells.

Beta cells (beta-cells, β-cells) are a type of cell in the pancreas in areas called the islets of Langerhans. They make up 65-80% of the cells in the islets.

Function

[編輯]

Beta cells make and release insulin, a hormone that controls the level of glucose in the blood. There is a baseline level of glucose maintained by the liver, but it can respond quickly to spikes in blood glucose by releasing stored insulin while simultaneously producing more. The response time is fairly quick, taking approximately 10 minutes.

Apart from insulin, beta cells release C-peptide, a byproduct of insulin production, into the bloodstream in equimolar quantities. C-peptide helps to prevent neuropathy and other symptoms of diabetes related to vascular deterioration[1]. Measuring the levels of C-peptide can give a practitioner an idea of the viable beta cell mass.[2]

β-cells also produce amylin,[3] also known as IAPP, islet amyloid polypeptide. Amylin functions as part of the endocrine pancreas and contributes to glycemic control. Amylin's metabolic function is now somewhat well characterized as an inhibitor of the appearance of nutrient [especially glucose] in the plasma. It thus functions as a synergistic partner to insulin. Whereas insulin regulates long term food intake, increased amylin decreases food intake in the short term.

Pathology

[編輯]
  • Diabetes mellitus type 1 is caused by the destruction or dysfunction of insulin-producing beta cells by the cells of the immune system.
  • Insulinoma is a rare tumor derived from beta cells. Insulinomas are usually benign and not malignant, but may be medically significant and even life-threatening due to recurrent and prolonged attacks of hypoglycemia.

Research

[編輯]

Much research is being done in the field of beta-cell physiology and pathology, focusing mostly on diabetes. Many researchers are trying to find ways to use these beta-cells to help control or prevent diabetes. A major topic is the replication of adult beta-cells and the application of these to diabetes. The Larry L. Hillblom Islet Research Center at UCLA[6] is a leading research center in the field, within the Diabetes and Endocrinology Research Center[7], directed by Dr. Peter Butler. [8]

A team science effort also exists, known as the Beta Cell Biology Consortium (BCBC).[9] The BCBC is responsible for facilitating interdisciplinary approaches that will advance the understanding of pancreatic islet development and function. The long-term goal of the BCBC is to develop a cell-based therapy for insulin delivery.

In a study presented on June 8, 2008 at the American Diabetes Association’s 68th Scientific Sessions, a team showed that mice lacking insulin receptors in their beta cells had problems in the processing of insulin leading to excess, unprocessed levels of the hormone. Unprocessed insulin is unable to properly control glucose levels in the body. High circulating levels of unprocessed insulin and insulin resistance, a condition in which normal amounts of insulin are inadequate to produce a normal insulin response, are both known to be early indicators of type 2 diabetes.[10]

See also

[編輯]

References

[編輯]
  1. ^ Y. Ido, A. Vindigni, K. Chang, L. Stramm, R. Chance, W. F. Heath, R. D. DiMarchi, E. Di Cera, J. R. Williamson. 1997. Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide. Science, Vol. 277. no. 5325, pp. 563 - 566.
  2. ^ Hoogwerf B, Goetz F. Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids. J Clin Endocrinol Metab. 1983, 56 (1): 60–7. PMID 6336620. doi:10.1210/jcem-56-1-60. 
  3. ^ Moore C, Cooper G. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun. 1991, 179 (1): 1–9. PMID 1679326. doi:10.1016/0006-291X(91)91325-7. 
  4. ^ U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995, 44 (11): 1249–58. PMID 7589820. doi:10.2337/diabetes.44.11.1249. 
  5. ^ Rudenski A, Matthews D, Levy J, Turner R. Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism. 1991, 40 (9): 908–17. PMID 1895955. doi:10.1016/0026-0495(91)90065-5. 
  6. ^ The Larry L. Hillblom Islet Research Center
  7. ^ The DERC Homepage has moved
  8. ^ Faculty
  9. ^ Beta Cell Biology Consortium
  10. ^ Newswise: Beta Cell Defect Linked to Type 2 Diabetes Retrieved on June 8, 2008.
[編輯]

Template:Endocrine pancreas